A Gray Zone Approach of Rotational Thromboelastometry for Predicting Postoperative Bleeding in Cardiac Surgical Patients
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01889732 |
Recruitment Status : Unknown
Verified June 2013 by Samsung Medical Center.
Recruitment status was: Recruiting
First Posted : June 28, 2013
Last Update Posted : June 28, 2013
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Other Functional Disturbances Following Cardiac Surgery Postoperative Hemorrhage Coagulation Defect; Bleeding | Device: ROTEM |
Study Type : | Observational |
Estimated Enrollment : | 200 participants |
Observational Model: | Cohort |
Time Perspective: | Retrospective |
Official Title: | The Effectiveness Evaluation of Rotational Thromboelastometry(ROTEM) for Predicting Postoperative Bleeding in Cardiac Surgical Patients Using a Gray Zone Approach : A Preliminary Retrospective Study |
Study Start Date : | June 2013 |
Estimated Primary Completion Date : | August 2013 |
Estimated Study Completion Date : | August 2013 |
Group/Cohort | Intervention/treatment |
---|---|
ROTEM |
Device: ROTEM |
- early postoperative bleeding(chest tube drainage) [ Time Frame: postoperative bleeding during 6hrs. ]primary outcome is Chest tube drainage(blood volume) during 6hrs.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 20 Years to 80 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- cardiac surgical patients using Cardiopulmonary bypass
Exclusion Criteria:
- known coagulation disorder
- Using deep hypothermic circulatory arrest
- Using partial cardiopulmonary bypass

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01889732
Contact: jonghwan lee, MD,PhD | 82-2-3410-1928 | jonghwan75.lee@samsung.com | |
Contact: eunhee kim, MD | 82-2-3410-2470 | eunhee0720.kim@samsung.com |
Korea, Republic of | |
Samsung Medical Center | Recruiting |
Seoul, Korea, Republic of, 135-710 | |
Contact: Jonghwan lee, MD,PhD 82-2-3410-1928 jonghwan75.lee@samsung.com | |
Contact: Eunhee Kim, MD 82-2-3410-2470 eunhee0720.kim@samsung.com | |
Principal Investigator: Jonghwan Lee, MD,PhD | |
Principal Investigator: Eunhee Kim, MD |
Principal Investigator: | jonghwan lee, MD, PhD | Samsung Medical Center | |
Principal Investigator: | eunhee kim, MD | Samsung Medical Center |
Responsible Party: | Samsung Medical Center |
ClinicalTrials.gov Identifier: | NCT01889732 |
Other Study ID Numbers: |
SMC 2013-05-060 |
First Posted: | June 28, 2013 Key Record Dates |
Last Update Posted: | June 28, 2013 |
Last Verified: | June 2013 |
Hemostatic Disorders Blood Coagulation Disorders Hemorrhage Postoperative Hemorrhage Pathologic Processes |
Postoperative Complications Hematologic Diseases Vascular Diseases Cardiovascular Diseases Hemorrhagic Disorders |